Sugi Predict

Sugi Predict / Compounds / SCHEMBL3535835

SCHEMBL3535835

SCHEMBL3535835

CCOC(=O)C(Cc1ccc(OCCN(C)c2cccc(CNCCOc3ccc(C[C@H](OCC)C(=O)OCC)cc3)n2)cc1)OCC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 16/20 0.47
▸ PPARA Q07869 10/20 0.47
▸ PPARD Q03181 2/20 0.41
▸ ITGB1 P05556 1/20 0.39
▸ ITGA5 P08648 1/20 0.39
▸ LTA4H P09960 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ GMNN O75496 1/20 0.39
▸ EGFR P00533 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ ADORA3 P0DMS8 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ ADRB3 P13945 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ ADRA2B P18089 1/20 0.39
▸ NFKB1 P19838 1/20 0.39
▸ TACR2 P21452 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3534804 0.92 PPARG (0.56) PPARGPPARAPPARD
SCHEMBL3542196 0.92 PPARG (0.56) PPARGPPARAPPARD
SCHEMBL3535841 0.88 PPARG (0.55) PPARGPPARAPPARD
SCHEMBL3535840 0.88 PPARG (0.55) PPARGPPARAPPARD
SCHEMBL3535837 0.88 PPARG (0.55) PPARGPPARAPPARD
SCHEMBL3537171 0.85 PPARG (0.61) PPARGPPARAPPARD
SCHEMBL3537181 0.85 PPARG (0.61) PPARGPPARAPPARD
SCHEMBL3537194 0.85 PPARG (0.61) PPARGPPARAPPARD
SCHEMBL3542211 0.79 PPARG (0.67) PPARGPPARAPPARD
SCHEMBL3542206 0.79 PPARG (0.67) PPARGPPARAPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1578716-A1 DICARBOXYLIC ACID DERIVATIVES AS PPAR-AGONISTS NOVO NORDISK A/S (DK) 2005-09-28 — — EP claimed
US-20040259950-A1 Novel compounds, their preparation and use HIGH POINT PHARMACEUTICALS, LLC 2004-12-23 — — US claimed
WO-2004056740-A1 DICARBOXYLIC ACID DERIVATIVES AS PPAR-AGONISTS NOVO NORDISK A/S (DK) 2004-07-08 — — WO claimed
US-7816385-B2 Dimeric dicarboxylic acid derivatives, their preparation and use HIGH POINT PHARMACEUTICALS, LLC (US) 2010-10-19 — — US disclosed
EP-1578716-A1 DICARBOXYLIC ACID DERIVATIVES AS PPAR-AGONISTS NOVO NORDISK A/S (DK) 2005-09-28 — — EP disclosed
US-20040259950-A1 Novel compounds, their preparation and use HIGH POINT PHARMACEUTICALS, LLC 2004-12-23 — — US disclosed
WO-2004056740-A1 DICARBOXYLIC ACID DERIVATIVES AS PPAR-AGONISTS NOVO NORDISK A/S (DK) 2004-07-08 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259950-A1 Novel compounds, their preparation and use PPARG, PPARA, PPARD PPARG 1/4885PPARA 2/4885PPARD 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.